Halma plc (LSE:HLMA) has acquired California-based Surgistar Inc. for $90 million in cash, on a debt-free, cash-free basis, using existing financing facilities.
The acquisition will be integrated into Halma’s Healthcare division through its MicroSurgical Technology (MST) business, strengthening its position in ophthalmic surgical instruments. Surgistar specialises in precision products such as blades, cannulas, and trephines, and brings highly automated manufacturing capabilities that are expected to support consistent quality and scalable growth.
The deal enhances MST’s product portfolio while benefiting from its established global distribution network, aligning with Halma’s strategy of pursuing targeted bolt-on acquisitions in high-growth medical technology segments. By broadening its ophthalmic offering, the group aims to reinforce its competitive position in the global eye surgery market and expand the scale of its healthcare operations without placing strain on its balance sheet.
From an investment perspective, Halma continues to benefit from strong financial performance and positive sentiment around its strategic execution. However, its relatively high valuation and modest dividend yield may temper overall investor appeal.
More about Halma plc
Halma plc is a global group of companies focused on life-saving technologies across safety, environmental, and healthcare markets. Listed on the FTSE 100, the group employs more than 9,000 people in over 20 countries, delivering products and solutions that improve safety, address environmental challenges, and support advances in healthcare worldwide.
Leave a Reply